TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2021 ,inter alia, to consider and approve We would like to inform you that the meeting of the Board of Directors will be held on Monday, 08-Feb-21, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on 31-Dec-20. The Board would also consider payment of Interim Dividend for the year 2020-21.